An Overview on Emerging Therapy for Cancer
K. Malleswari1*, Dr. Rama Brahma Reddy2* A. Bindu Madhavi3*, T.Sri Vallika4*, Sk. Anjum5*
1*Associate professor, Department of Pharmaceutics, Nalanda Institute of Pharmaceutical Sciences, JNTUK University
2* Principal and Professor, Department of Phytochemistry, Nalanda Institute of Pharmaceutical Sciences, JNTUK University
345* Students, Department of B. Pharmacy, Nalanda Institute of Pharmaceutical Sciences, JNTUK University
Guntur, Andhra Pradesh, India
Malleswarikunchala105@gmail.com
ABSTRACT - Cancer is a global health problem responsible for one in six deaths worldwide. Treating cancer has been a highly complex process. Conventional treatment approaches, such as surgery, chemotherapy, and radiotherapy, have been in use, while significant advances are being made in recent times, including stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, sonodynamic therapy, and ferroptosis-based therapy. Current methods in oncology focus on the development of safe and efficient cancer nanomedicines. Stem cell therapy has brought promising efficacy in regenerating and repairing diseased or damaged tissues by targeting both primary and metastatic cancer foci, and nanoparticles brought new diagnostic and therapeutic options. Targeted therapy possessed breakthrough potential inhibiting the growth and spread of specific cancer cells, causing less damage to healthy cells. Ablation therapy has emerged as a minimally invasive procedure that burns or freezes cancers without the need for open surgery. Natural antioxidants demonstrated potential tracking down free radicals and neutralizing their harmful effects thereby treating or preventing cancer. Several new technologies are currently under research in clinical trials, and some of them have already been approved. This review presented an update on recent advances and breakthroughs in cancer therapies.
Keywords: Cancer, treatment, stem cell, targeted drugs, natural antioxidants, gene therapy.
